Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 4, 2012, Pages 744-749

  Seaman, Bradley J ^a   Guardiani, Elizabeth A ^a   Brewer, Carmen C ^b   Zalewski, Christopher K ^b   King, Kelly A ^b   Rudy, Susan ^b   Van Waes, Carter ^b   Morgan, Richard A ^c   Dudley, Mark E ^c   Yang, James C ^c   Rosenberg, Steven A ^c   Kim, H Jeffrey ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

adoptive cell immunotherapy; audiovestibular dysfunction; cochlea; hearing loss; melanocytes; melanoma; stria vascularis; vestibular dysfunction; vestibular organs

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; METHYLPREDNISOLONE;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; AUDIOLOGY; CANCER PATIENT; CLINICAL ARTICLE; COCHLEA; CONTROLLED STUDY; HEARING IMPAIRMENT; HUMAN; INFUSION; MELANOCYTE; METASTATIC MELANOMA; NYSTAGMOGRAPHY; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; STABILOGRAPHY; T LYMPHOCYTE; TERTIARY HEALTH CARE; VESTIBULAR DISORDER; VESTIBULAR TEST;

ADAPTIVE IMMUNITY; ADULT; AUDIOMETRY, PURE-TONE; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; GP100 MELANOMA ANTIGEN; HEARING LOSS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; MALE; MART-1 ANTIGEN; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; VESTIBULAR FUNCTION TESTS;

EID: 84870412110     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812448356     Document Type: Article

References (13)

1. Johnson L, Morgan R, Dudley M, et al. Gene therapy with mouse and human T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood. 2009 ; 114: 535-546
2. Johnson LA, Heemskerk B, Powell DJ, et al. Gene transfer of tumor-reactive TCR confers both high-avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor infiltrating lymphocytes. J Immunol. 2006 ; 177: 6548-6559 (Pubitemid 44628874)
3. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA. 1994 ; 91: 6458-6462
4. Palmer DC, Chan C, Gattinoni L. Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci USA. 2008 ; 205 8061: 8066 (Pubitemid 351904708)
5. Yeh S, Karne NK, Kerkar SP, et al. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology. 2009 ; 116: 981-989
6. Tachibana M. Cochlear melanocytes and MITF signaling. J Investig Dermatol Symp Proc. 2000 ; 6: 95-98 (Pubitemid 33758612)
7. McGee J, Walsh EJ Cummings Otolaryngology-Head and Neck Surgery. 4 th ed.Philadelphia, PA: Mosby; 2005. Cummings CW Flint PW Harker LA, ed. Philadelphia, PA: Mosby ; 2005 :
8. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA. 1994 ; 36 (3). 11-19
9. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007 ; 117: 3-15 (Pubitemid 46066055)
10. Ciuman RR. Stria vascularis and vestibular dark cells: characterization of main structures responsible for inner-ear homeostasis and their pathological relations. J Laryngol Otol. 2009 ; 123: 151-162
11. Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci. 2006 ; 47: 2547-2554 (Pubitemid 351639840)
12. Barin K, Durrant JD. The Ear: Comprehensive Otology. Canalis RF Lempert PR, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2000 :
13. Steyger PS. Potentiation of chemical ototoxcity by noise. Semin Hear. 2009 ; 30: 38-46